Hemostats And Tissue Sealants Market Growth To $5.97 Billion Creates New Opportunities Across The Industry
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Hemostats And Tissue Sealants Market CAGR Outlook And Future Development
The hemostats and tissue sealants market size has exhibited robust growth over the past few years. Projections indicate that it will increase from $4.35 billion in 2025 to $4.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. Key drivers of this historical growth include the widespread use of traditional mechanical hemostats, the constrained supply of synthetic sealants, a rise in the number of surgical operations, the development of hospital infrastructure, and the early incorporation of fibrin-based sealants.
The hemostats and tissue sealants market size is anticipated to undergo significant expansion in the upcoming years. It is projected to reach $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The projected increase during this period is attributable to the emergence of next-generation tissue adhesives, an escalation in minimally invasive surgeries, a rise in cardiovascular and trauma surgeries, intensified research into hemostasis technologies, and the broadened reach of direct and online distribution channels. Prominent developments in the forecast period encompass a growing embrace of advanced hemostatic products, increased utilization of synthetic and combination sealants, an expansion of cardiovascular and trauma surgeries, a focus on minimally invasive procedures for faster recovery, and the increasing application of research and academic studies in hemostasis.
Get A Free Sample Report With In-Depth Market Insights:
Hemostats And Tissue Sealants Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing volume of surgical procedures is anticipated to fuel the growth of the hemostats and tissue sealants market moving forward. Surgical procedures refer to medical operations that involve manual and instrumental techniques carried out by surgeons to diagnose, treat, or remove diseased tissues or organs, or to repair bodily functions. The uptick in surgical procedures is attributed to the rising prevalence of chronic diseases, which frequently demand surgical intervention for effective management, treatment, or to prevent complications. Hemostats and tissue sealants support surgical procedures by effectively managing bleeding and sealing tissues, thereby minimizing complications and improving patient outcomes. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, reported a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Therefore, the escalating number of surgical procedures is driving the expansion of the hemostats and tissue sealants market.
Hemostats And Tissue Sealants Market Segmentation: How Does The Market Break Down By Category?
The hemostats and tissue sealants market covered in this report is segmented –
1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types
2) By Composition: Biological Based, Synthetic Based, Combination
3) By Distribution Channel: Direct Sales, Distributors, Online Sales
4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications
5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes
Subsegments:
1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats
2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives
3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants
4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats
#Hemostats And Tissue Sealants Market Growth Trends: What’s Shaping The Future Outlook?
Major companies operating in the hemostat and tissue sealants market are prioritizing the development of advanced products, such as ready-to-use absorbable collagen pads for hemostasis, to enhance efficiency and improve outcomes in surgical care. These ready-to-use absorbable collagen pads incorporate bioactive, resorbable materials that allow for immediate application without preparation, thereby enabling quick and effective tissue and dura sealing, as well as hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare company, introduced its Hemopatch Sealing Hemostat, which offers room temperature storage, at a symposium held in Austria. This new room temperature Hemopatch sealing hemostat provides ready-to-use convenience by eliminating the need for pre-warming, allowing for rapid application during surgery. It is an innovative absorbable pad that can be directly applied during both open and minimally invasive surgeries, removing any requirements for product preparation or refrigeration. The product’s powerful adhesive properties, extended shelf life, and rapid hemostatic effect assist surgeons in more efficiently managing bleeding or leakage, ultimately supporting improved surgical precision and patient recovery across various specialties.
Hemostats And Tissue Sealants Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.
View The Full Hemostats And Tissue Sealants Market Report:
Hemostats And Tissue Sealants Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
